Celldex Therapeutics (TCE2.MU) Q3 2026 Earnings

6AugConfirmed
Q2 2026
Next
-1.01
-0.97
-0.94
-0.91

Details

Expected EPS
-0.9076355035999999
Actual EPS
N/A
Surprise EPS
0.91
Surprise Percent
+100%

Description

Celldex Therapeutics (TCE2.MU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts